ReviewCardiovascular research2022

Treatment and prevention of lipoprotein(a)-mediated cardiovascular disease: the emerging potential of RNA interference therapeutics.

Daniel I Swerdlow et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.